Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 115

1.

Heart disease and hormones.

Coulter SA.

Tex Heart Inst J. 2011;38(2):137-41. No abstract available.

2.

Menopause: studying the research.

Pace DT.

Nurse Pract. 2006 Aug;31(8):17-23; quiz 23-5. Review. No abstract available.

PMID:
16966972
3.

Hormone replacement therapy and cardioprotection: a new dawn? A statement of the Study Group on Cardiovascular Disease in Women of the Italian Society of Cardiology on hormone replacement therapy in postmenopausal women.

Rosano GM, Maffei S, Andreassi MG, Vitale C, Vassalle C, Gambacciani M, Stramba-Badiale M, Mercuro G.

J Cardiovasc Med (Hagerstown). 2009 Jan;10(1):85-92. doi: 10.2459/JCM.0b013e328313e979.

PMID:
19145119
4.

After menopause: novel marker helps to identify women at risk for heart disease.

Lewis SL.

J Fam Pract. 2004 Jul;Suppl:S18-24. Review. No abstract available.

PMID:
15251109
5.
6.

Guidelines update on the prevention of heart disease in women.

Caboral MF, King WV, Goolsby MJ.

J Am Acad Nurse Pract. 2008 Apr;20(4):191-3. doi: 10.1111/j.1745-7599.2008.00309.x. No abstract available.

PMID:
18387015
7.

Lessons from the Women's Health Initiative: primary prevention and gender health.

Day A.

CMAJ. 2002 Aug 20;167(4):361-2. No abstract available.

8.

Hold the hormones? The good and the bad about postmenopausal estrogen therapy.

Nemecek S.

Sci Am. 1997 Sep;277(3):38, 40. No abstract available.

PMID:
9304196
9.

Heart health and older women.

Robinson AW, Sloan HL.

J Gerontol Nurs. 2000 May;26(5):38-45. Review. No abstract available.

PMID:
11111519
10.

Perspectives on the Women's Health Initiative trial of hormone replacement therapy.

Grimes DA, Lobo RA.

Obstet Gynecol. 2002 Dec;100(6):1344-53. Review.

PMID:
12468183
11.

Menopausal hormone replacement therapy.

Varner RE.

Curr Womens Health Rep. 2003 Oct;3(5):410-7. Review.

PMID:
12959701
12.

Health risks after cessation of postmenopausal hormone therapy.

Pines A, Sturdee D, Birkhäuser M; International Menopause Society..

Climacteric. 2008 Jun;11(3):179-80. doi: 10.1080/13697130802176228. No abstract available.

PMID:
18568782
13.

The SOGC statement on the WHI report on estrogen and progestin use in postmenopausal women.

Blake JM, Collins JA, Reid RL, Fedorkow DM, Lalonde AB, Christilaw J, Fortier M, Fortin C, Jolly EE, Lemay A, O'Grady T, Smith TE, Cooper J, Maxted JM, O'Grady K, Turek MA; SOGC (Society of Obstetricians and Gynaecologists of Canada)..

J Obstet Gynaecol Can. 2002 Oct;24(10):783-90, 793-802. English, French.

PMID:
12399806
14.

Hormone replacement therapy: a time for pause.

Yusuf S, Anand S.

CMAJ. 2002 Aug 20;167(4):357-9. Review. No abstract available.

15.

Hormones, menopause, and heart disease: making sense of the Women's Health Initiative.

Derry PS.

Womens Health Issues. 2004 Nov-Dec;14(6):212-9. Review.

PMID:
15589771
16.
17.
18.

Tipping the balance: the WHI study and the benefits and risks of hormone replacement therapy. Women's Health Initiative.

Collins JA.

J Obstet Gynaecol Can. 2002 Sep;24(9):683-8. English, French. No abstract available.

PMID:
12360360
19.

Postmenopausal hormone replacement therapy and the prevention of cardiovascular disease: a review.

Abramson BL.

J Cardiovasc Risk. 2002 Dec;9(6):309-14. Review.

PMID:
12478199
20.

Supplemental Content

Support Center